NCT00700960已完成不适用
Observational Study on Efficacy on Glycaemic Control of Slow-acting Insulin Analogue in Type 2 Diabetes
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,745
- 试验地点
- 1
- 主要终点
- HbA1c
研究概览
简要总结
This study is conducted in Europe. The aim of this observational study is to describe the conditions for the concomitant administration of a slow-acting insulin analogue with oral antidiabetics (OADs) in order to improve blood glucose control in type 2 diabetes.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes
- •HbA1c level greater than 7% despite treatment with two (or three) oral antidiabetic drugs (OADs) at an optimal dose level
- •Patient agreeing to take part in the study and capable of completing a self-questionnaire.
排除标准
- •Hypersensitivity to insulin or to one of the excipients
- •Treatment with insulin for at least 6 months
- •Participant in a clinical trial for diabetes on entry into the observational study
研究组 & 干预措施
A
干预措施: insulin detemir (Drug)
结局指标
主要结局
HbA1c
时间窗: After 3 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes MellitusDiabetesDiabetes Mellitus, Type 2NCT00687284Novo Nordisk A/S2,188
已完成
不适用
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00676741Novo Nordisk A/S3,809
已完成
不适用
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2NCT00670722Novo Nordisk A/S6,500
已完成
不适用
Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.DiabetesDiabetes Mellitus, Type 2NCT00793273Novo Nordisk A/S1,074
已完成
不适用
Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)DiabetesDiabetes Mellitus, Type 2NCT00657930Novo Nordisk A/S2,289